Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Inflammatory Response and Barrier Dysfunction by Different e-Cigarette Flavoring Chemicals Identified by Gas Chromatography-Mass Spectrometry in e-Liquids and e-Vapors on Human Lung Epithelial Cells and Fibroblasts.

Gerloff J, Sundar IK, Freter R, Sekera ER, Friedman AE, Robinson R, Pagano T, Rahman I.

Appl In Vitro Toxicol. 2017 Mar 1;3(1):28-40. doi: 10.1089/aivt.2016.0030.

2.

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.

Falletta P, Sanchez-Del-Campo L, Chauhan J, Effern M, Kenyon A, Kershaw CJ, Siddaway R, Lisle R, Freter R, Daniels MJ, Lu X, Tüting T, Middleton M, Buffa FM, Willis AE, Pavitt G, Ronai ZA, Sauka-Spengler T, Hölzel M, Goding CR.

Genes Dev. 2017 Jan 1;31(1):18-33. doi: 10.1101/gad.290940.116. Epub 2017 Jan 17.

3.

Cranial neural crest cells form corridors prefiguring sensory neuroblast migration.

Freter S, Fleenor SJ, Freter R, Liu KJ, Begbie J.

Development. 2013 Sep;140(17):3595-600. doi: 10.1242/dev.091033.

4.

Directed phenotype switching as an effective antimelanoma strategy.

Sáez-Ayala M, Montenegro MF, Sánchez-Del-Campo L, Fernández-Pérez MP, Chazarra S, Freter R, Middleton M, Piñero-Madrona A, Cabezas-Herrera J, Goding CR, Rodríguez-López JN.

Cancer Cell. 2013 Jul 8;24(1):105-19. doi: 10.1016/j.ccr.2013.05.009. Epub 2013 Jun 20.

5.

Niche work when you can get it: collagen XVII and the melanocyte stem cell.

Freter R.

Pigment Cell Melanoma Res. 2011 Aug;24(4):592-3. No abstract available.

PMID:
22489331
6.

Adult stem cells exhibit global suppression of RNA polymerase II serine-2 phosphorylation.

Freter R, Osawa M, Nishikawa S.

Stem Cells. 2010 Sep;28(9):1571-80. doi: 10.1002/stem.476.

7.

Niche required for inducing quiescent stem cells.

Nishikawa SI, Osawa M, Yonetani S, Torikai-Nishikawa S, Freter R.

Cold Spring Harb Symp Quant Biol. 2008;73:67-71. doi: 10.1101/sqb.2008.73.024. Epub 2008 Nov 6. Review.

PMID:
19022757
8.

Molecular characterization of melanocyte stem cells in their niche.

Osawa M, Egawa G, Mak SS, Moriyama M, Freter R, Yonetani S, Beermann F, Nishikawa S.

Development. 2005 Dec;132(24):5589-99.

9.

Diagnosis of ovarian cancer metastatic to the stomach by EUS-guided FNA.

Sangha S, Gergeos F, Freter R, Paiva LL, Jacobson BC.

Gastrointest Endosc. 2003 Dec;58(6):933-5. No abstract available.

PMID:
14652570
10.

Platelet-derived growth factor-stimulated expression of the MCP-1 immediate-early gene involves an inhibitory multiprotein complex.

Sridhar P, Liu Y, Chin LD, Borja CE, Mann M, Skopicki HA, Freter RR.

Mol Cell Biol. 1999 Jun;19(6):4219-30.

11.

Platelet-derived growth factor induction of the immediate-early gene MCP-1 is mediated by NF-kappaB and a 90-kDa phosphoprotein coactivator.

Freter RR, Alberta JA, Hwang GY, Wrentmore AL, Stiles CD.

J Biol Chem. 1996 Jul 19;271(29):17417-24.

13.
14.

Role of gram-negative and gram-positive gastrointestinal flora in temperature regulation of mice.

Conn CA, Franklin B, Freter R, Kluger MJ.

Am J Physiol. 1991 Dec;261(6 Pt 2):R1358-63.

PMID:
1750560
15.

Effect of gastrointestinal flora on body temperature of rats and mice.

Kluger MJ, Conn CA, Franklin B, Freter R, Abrams GD.

Am J Physiol. 1990 Feb;258(2 Pt 2):R552-7.

PMID:
2309941
17.

Control mechanisms of the large-intestinal microflora and its influence on the host.

Freter R.

Acta Gastroenterol Latinoam. 1989;19(4):197-217. Review. No abstract available.

PMID:
2701204
19.

Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli.

Wilson KH, Sheagren JN, Freter R, Weatherbee L, Lyerly D.

J Infect Dis. 1986 Mar;153(3):547-51.

PMID:
3512730
20.

Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster.

Wilson KH, Sheagren JN, Freter R.

J Infect Dis. 1985 Feb;151(2):355-61.

PMID:
3968453
22.
23.

Models for studying the role of bacterial attachment in virulence and pathogenesis.

Freter R, Jones GW.

Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S647-58. Review.

PMID:
6356286
24.

Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Hagberg L, Engberg I, Freter R, Lam J, Olling S, Svanborg Edén C.

Infect Immun. 1983 Apr;40(1):273-83.

25.

Contribution of adhesion to bacterial persistence in the mouse urinary tract.

Hagberg L, Hull R, Hull S, Falkow S, Freter R, Svanborg Edén C.

Infect Immun. 1983 Apr;40(1):265-72.

26.

Survival and implantation of Escherichia coli in the intestinal tract.

Freter R, Brickner H, Fekete J, Vickerman MM, Carey KE.

Infect Immun. 1983 Feb;39(2):686-703.

27.

Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora.

Freter R, Brickner H, Botney M, Cleven D, Aranki A.

Infect Immun. 1983 Feb;39(2):676-85.

28.

Continuous-flow cultures as in vitro models of the ecology of large intestinal flora.

Freter R, Stauffer E, Cleven D, Holdeman LV, Moore WE.

Infect Immun. 1983 Feb;39(2):666-75.

29.
30.

Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue.

Edén CS, Freter R, Hagberg L, Hull R, Hull S, Leffler H, Schoolnik G.

Nature. 1982 Aug 5;298(5874):560-2.

31.

Selective antimicrobial modulation of human microbial flora.

Wilson KH, Sheagren JN, Freter RG.

J Infect Dis. 1982 Mar;145(3):427-9. No abstract available.

PMID:
7061889
32.

Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies.

Freter R, Allweiss B, O'Brien PC, Halstead SA, Macsai MS.

Infect Immun. 1981 Oct;34(1):241-9.

33.
36.

Mechanisms of association of bacteria with mucosal surfaces.

Freter R.

Ciba Found Symp. 1981;80:36-55. Review.

PMID:
7021088
37.

Proofreading systems of multiple stages for improved accuracy of biological discrimination.

Freter RR, Savageau MA.

J Theor Biol. 1980 Jul 7;85(1):99-123. No abstract available.

38.

On the evolution of accuracy and cost of proofreading tRNA aminoacylation.

Savageau MA, Freter RR.

Proc Natl Acad Sci U S A. 1979 Sep;76(9):4507-10.

39.

Energy cost of proofreading to increase fidelity of transfer ribonucleic acid aminoacylation.

Savageau MA, Freter RR.

Biochemistry. 1979 Aug 7;18(16):3486-93.

PMID:
258151
40.

Effect of chemotaxis on the interaction of cholera vibrios with intestinal mucosa.

Freter R, O'Brien PC, Macsai MS.

Am J Clin Nutr. 1979 Jan;32(1):128-32.

PMID:
760498
41.

Possible effects of foreign DNA on pathogenic potential and intestinal proliferation of Escherichia coli.

Freter R.

J Infect Dis. 1978 May;137(5):624-9. No abstract available.

PMID:
351075
42.

Adhesion and chemotaxis as determinants of bacterial association with mucosal surfaces.

Freter R, O'Brien PC, Halstead SA.

Adv Exp Med Biol. 1978;107:429-37.

PMID:
369312
43.

The role of chemotaxis in the ecology of bacterial pathogens of mucosal surfaces.

Allweiss B, Dostal J, Carey KE, Edwards TF, Freter R.

Nature. 1977 Mar 31;266(5601):448-50. No abstract available.

46.
47.

Interactions between mechanisms controlling the intestinal microflora.

Freter R.

Am J Clin Nutr. 1974 Dec;27(12):1409-16. No abstract available.

PMID:
4611192
48.

Synergism between ecologic and immunologic control mechanisms of intestinal flora.

Shedlofsky S, Freter R.

J Infect Dis. 1974 Mar;129(3):296-303. No abstract available.

PMID:
4205879
49.

Protection against enteric bacterial infection by secretory IgA antibodies.

Fubara ES, Freter R.

J Immunol. 1973 Aug;111(2):395-403. No abstract available.

PMID:
4197984
50.

Source and protective function of coproantibodies in intestinal disease.

Fubara ES, Freter R.

Am J Clin Nutr. 1972 Dec;25(12):1357-63. No abstract available.

PMID:
4639750

Supplemental Content

Loading ...
Support Center